Hauk, V <br/><br/>
Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis.  [electronic resource] 

 -  Clinical and experimental immunology  Sep 2014 
 - 662-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2249 
<br/><br/><label>Standard No.: </label>10.1111/cei.12378  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Apoptosis<br/>Case-Control Studies<br/>Cytophagocytosis--drug effects<br/>Gene Expression Regulation--drug effects<br/>Humans<br/>Lipopolysaccharides--immunology<br/>Middle Aged<br/>Monocytes--drug effects<br/>Receptors, Vasoactive Intestinal Peptide<br/>Receptors, Vasoactive Intestinal Peptide, Type II--genetics<br/>Sjogren's Syndrome--genetics<br/>Vasoactive Intestinal Peptide--pharmacology<br/>Young Adult